Tag: cervix
Positive Phase II Trial Results for Tisotumab Vedotin Cervical Cancer
The phase II innovaTV 204 trial, a single-arm clinical trial also known as GCT1015-04 or GOG-3023/ENGOT-cx6 (NCT03438396), evaluating tisotumab vedotin administered every three weeks...